EC approves combination treatment for kidney cancer
March 31, 2021Research and Development Cancer, Europe, oncology
The European Commission (EC) has approved Ipsen’s Cabometyx in combination with Opdivo as a first-line treatment for advanced renal cell …
Celonic to manufacture at least 100 million CureVac COVID-19 jabs
March 31, 2021Research and Development COVID-19, COVID-19 vaccine, CureVac, colonic, vaccine production
Celonic are to manufacture more than 100 million doses of CureVac’s COVID-19 vaccine, with 50 million shots expected to be …
Arecor receives £2.8m grant for rapid insulin product
March 31, 2021Research and Development diabetes, insulin
Arecor has announced today that it has received a £2.8 million grant from Innovate UK, to support the Phase II …
J & J to ship up to 400 million vaccines to Africa
March 30, 2021Manufacturing and Production COVAX, COVID-19, COVID-19 vaccine, Janssen, Johnson & Johnson
Johnson & Johnson has reached an agreement to ship as many as 400 million doses of their COVID-19 vaccine to …
Roche’s SMA treatment Evrysdi approved by European Commission
March 30, 2021Manufacturing and Production EMA, European Commission, PTC Therapeutics, Roche, sma, spinal muscular atrophy
The European Commission has granted marketing authorisation to Roche and PTC Therapeutics’ Evrysdi, for the treatment of patients aged 2 …
Novartis expands targeted radioligand therapy pipeline
March 30, 2021Manufacturing and Production
Novartis has announced today that it has obtained exclusive rights to develop therapeutic applications for a library of fibroblast activation …
GSK to support manufacture of 60m Novavax COVID-19 vaccines
March 30, 2021Manufacturing and Production COVID-19, GSK, UK, Vaccine
GSK has reached an agreement with Novavax and the UK Government Vaccines Taskforce to support the production of up to …
Incyte receives EC approval for Pemazyre
March 30, 2021Manufacturing and Production EU
Incyte have received approval from the European Commission (EC) for Pemazyre (pemigatinib), the first new treatment for adults with locally …
500,000 Moderna COVID-19 vaccines to arrive in UK next month
March 29, 2021Sales and Marketing COVID-19, Moderna, Vaccine
More than 500,000 doses of Moderna’s COVID-19 vaccine are set to arrive in the UK next month, ministers have confirmed. …
GSK & Vir’s COVID-19 treatment shows 85% efficacy in Phase III trial
March 29, 2021Sales and Marketing COVID-19, GSK, Phase III trial, covid-19 treatment, vir
GSK and Vir Biotechnology have submitted an Emergency Use Authorization request to the FDA for their VIR-7831 therapy for the …
Janssen’s multiple sclerosis treatment recommended by EMA
March 29, 2021Sales and Marketing CHMP, EMA, Janssen, Johnson & Johnson, PONVORY, multiple sclerosis
Janssen’s PONVORY therapy for the treatment of adults with relapsing forms of multiple sclerosis (MS) has been recommended by the …
BATM develops molecular diagnostics test for tuberculosis
March 29, 2021Sales and Marketing TB, testing
BATM have announced that it has developed a new method for the rapid and comprehensive diagnosis of tuberculosis (TB), which …
gaitQ awarded NIHR grant for Parkinson’s wearable tech
March 29, 2021Sales and Marketing Parkinson's, medical technology
The UK’s National Institute for Health Research (NIHR) has awarded a £135,000 grant to gaitQ, a spin-off from the University …
Pharmafile.com’s top 10 news stories of the week
March 26, 2021Medical Communications AstraZeneca vaccine, COVID-19, covid 19 news, covid-19 news, news, news roundup, starpharma
In the last week, a number of new developments have made the news; for COVID-19, Starpharma will begin to sell …
FDA approve Astellas’s Myrbetriq treatment for bladder dysfunction
March 26, 2021Medical Communications Astellas Pharma, FDA, Ida approval
The FDA have approved a new indication for Astellas Pharma’s Myrbetriq and Myrbetriq Granules to treat neurogenic detrusor overactivity (NDO), …
Astellas Pharma and Seagen cancer treatment gets MAA acceptance from EMA
March 26, 2021Medical Communications EMA, oncology
Astellas Pharma and Seagen Inc. have announced that the EMA has accepted their marketing authorisation application (MAA) for enfortumab vedotin, …
Novavax delays 100 million vaccines to the EU
March 26, 2021Medical Communications COVID-19, EU, Vaccine
Novavax is delaying the signing of a contract to supply COVID-19 vaccines to the EU, as the company warned it …
Pfizer begins COVID-19 vaccine testing on young children
March 26, 2021Medical Communications COVID-19, Pfizer, Vaccine
Pfizer have begun testing its COVID-19 vaccine on children under the age of 12, with the trials’ first participants, a …
Starpharma to sell COVID-fighting nose spray in UK
March 25, 2021COVID-19
Australian biotech company, Starpharma, has announced a deal with LloydsPharmacy to sell its COVID-fighting antiviral nasal spray, Viraleze, in the …
Merck and UCLA find new COVID-19 treatment candidate
March 25, 2021COVID-19, Merck, berzosertib, covid-19 treatment, ucla
Merck (MSD in the UK), the UCLA, and other universities from the US and Germany have uncovered a compound that …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
